About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 232863, 9 pages
http://dx.doi.org/10.1155/2012/232863
Research Article

Molecular Imaging of Mesothelioma with 9 9 m T c -ECG and 6 8 G a -ECG

Department of Experimental Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, P.O. Box 59, 1515 Holcombe Boulevard, Houston, TX 77030, USA

Received 6 January 2012; Revised 9 February 2012; Accepted 16 February 2012

Academic Editor: Lie-Hang Shen

Copyright © 2012 Yin-Han Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Buerkle and W. A. Weber, “Imaging of tumor glucose utilization with positron emission tomography,” Cancer and Metastasis Reviews, vol. 27, no. 4, pp. 545–554, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Delbeke, R. E. Coleman, M. J. Guiberteau et al., “Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0,” Journal of Nuclear Medicine, vol. 47, no. 5, pp. 885–895, 2006. View at Scopus
  3. M. G. Buse, “Hexosamines, insulin resistance and the complications of diabetes: current status,” American Journal of Physiology, vol. 290, pp. 1–15, 2006.
  4. S. P. N. Iyer and G. W. Hart, “Dynamic nuclear and cytoplasmic glycosylation: enzymes of O-GlcNAc cycling,” Biochemistry, vol. 42, no. 9, pp. 2493–2499, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Mang'era, H. Vanbilloen, B. Cleynhens et al., “Synthesis and evaluation of the T99mc-complexes of L-cysteine acetyldiglycine (a hybrid of MAG3 and L,L-EC) and of L-β-homocysteine acetyldiglycine,” Nuclear Medicine and Biology, vol. 27, no. 8, pp. 781–789, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. H. P. Vanbilloen, B. J. Cleynhens, and A. M. Verbruggen, “Synthesis and biological evaluation of the four isomers of technetium-99m labeled ethylenecysteamine cysteine (T99mc-ECC), the mono-acid derivative of T99mc-L,L-ethylenedicysteine,” Nuclear Medicine and Biology, vol. 27, no. 2, pp. 207–214, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. D. J. Yang, S. Ilgan, T. Higuchi et al., “Noninvasive assessment of tumor hypoxia with T99mc labeled metronidazole,” Pharmaceutical Research, vol. 16, no. 5, pp. 743–750, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Yang, A. Azhdarinia, P. Wu et al., “In vivo and in vitro measurement of apoptosis in breast cancer cells using T99mc-EC-annexin V,” Cancer Biotherapy and Radiopharmaceuticals, vol. 16, no. 1, pp. 73–83, 2001. View at Scopus
  9. D. J. Yang, W. E. Fogler, J. L. Bryant et al., “Assessment of antiangiogenic effect using T99mc-EC-endostatin,” Cancer Biotherapy and Radiopharmaceuticals, vol. 17, no. 2, pp. 233–246, 2002. View at Scopus
  10. N. R. Schechter, D. J. Yang, A. Azhdarinia et al., “Assessment of epidermal growth factor receptor with T99mc-ethylenedicysteine-C225 monoclonal antibody,” Anti-Cancer Drugs, vol. 14, no. 1, pp. 49–56, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. D. J. Yang, C. G. Kim, N. R. Schechter et al., “Imaging with T99mc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents,” Radiology, vol. 226, no. 2, pp. 465–473, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. H. C. Song, H. S. Bom, K. H. Cho et al., “Prognostication of recovery in patients with acute ischemic stroke using brain spect with T99mc-labeled metronidazole,” Stroke, vol. 34, no. 4, pp. 982–986, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. D. J. Yang, J. Bryant, J. Y. Chang et al., “Assessment of cyclooxygense-2 expression with T99mc-labeled celebrex,” Anti-Cancer Drugs, vol. 15, no. 3, pp. 255–263, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. Yang, M. Yukihiro, C. S. Oh, et al., “Assessment of therapeutic tumor response using T99mc-Ethylenedicysteine-Glucosamine,” Cancer Biotherapy and Radiopharm, vol. 19, no. 4, pp. 444–458, 2004.
  15. N. R. Schechter, R. E. Wendt, D. J. Yang et al., “Radiation dosimetry of T99mc-labeled C225 in patients with squamous cell carcinoma of the head and neck,” Journal of Nuclear Medicine, vol. 45, no. 10, pp. 1683–1687, 2004. View at Scopus
  16. D. J. Yang, K. Ozaki, C. S. Oh et al., “T99mc-EC-guanine: synthesis, biodistribution, and tumor imaging in animals,” Pharmaceutical Research, vol. 22, no. 9, pp. 1471–1479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Ito, D. J. Yang, O. Mawlawi et al., “PET and Planar Imaging of Tumor Hypoxia With Labeled Metronidazole,” Academic Radiology, vol. 13, no. 5, pp. 598–609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Gong, D. Yang, S. Kohanim, R. Humphreys, L. Broemeling, and R. Kurzrock, “Novel In vivo imaging shows up-regulation of death receptors by paclitaxel and correlates with enhanced antitumor effects of receptor agonist antibodies,” Molecular Cancer Therapeutics, vol. 5, no. 12, pp. 2991–3000, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Kurihara, D. J. Yang, M. Cristofanilli et al., “Imaging and dosimetry of T99mc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors,” Applied Radiation and Isotopes, vol. 66, no. 9, pp. 1175–1182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Kayser, G. Böhm, S. Blum, et al., “Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients,” The Journal of Pathology, vol. 193, no. 2, pp. 175–180, 2001.
  21. S. Rastogi, S. Banerjee, S. Chellappan, and G. R. Simon, “Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines,” Cancer Letters, vol. 257, no. 2, pp. 244–251, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. D. Schulz, K. A. Zubris, J. E. Wade, et al., “Paclitaxel-loaded expansile nanoparticles in a multimodal treatment model of malignant mesothelioma,” The Annals of Thoracic Surgery, vol. 92, no. 6, pp. 2007–2013, 2011.
  23. S. Marshall, V. Bacote, and R. R. Traxinger, “Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system: role of hexosamine in the induction of insulin resistance,” Journal of Biological Chemistry, vol. 266, no. 8, pp. 4706–4712, 1991. View at Scopus
  24. A. Scheepers, H. G. Joost, and A. Schürmann, “The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function,” Journal of Parenteral and Enteral Nutrition, vol. 28, no. 5, pp. 364–371, 2004. View at Scopus
  25. L. Wells, K. Vosseller, and G. W. Hart, “Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc,” Science, vol. 291, no. 5512, pp. 2376–2378, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. N. R. Schechter, W. D. Erwin, D. J. Yang et al., “Radiation dosimetry and biodistribution of T99mc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 10, pp. 1583–1591, 2009. View at Publisher · View at Google Scholar · View at Scopus